210 related articles for article (PubMed ID: 2971078)
21. Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas.
Mogensen CE
Diabetologia; 1999 Mar; 42(3):263-85. PubMed ID: 10096778
[No Abstract] [Full Text] [Related]
22. Hypertension and microalbuminuria as predictors of diabetic nephropathy.
Jones SL; Viberti GC
Diabete Metab; 1989; 15(5 Pt 2):327-32. PubMed ID: 2612717
[TBL] [Abstract][Full Text] [Related]
23. Blood pressure reduction as a preventive treatment of diabetic nephropathy.
Ribstein J; Mimran A
Clin Invest Med; 1991 Dec; 14(6):661-70. PubMed ID: 1794216
[TBL] [Abstract][Full Text] [Related]
24. The natural course of glomerular filtration rate and arterial blood pressure in diabetic nephropathy, and the effect of antihypertensive treatment.
Parving HH; Andersen AR; Smidt U; Friisberg B; Bonnevie-Nielsen V; Svendsen PA
Acta Endocrinol Suppl (Copenh); 1981; 242():39-40. PubMed ID: 6940399
[No Abstract] [Full Text] [Related]
25. Reduced albuminuria during early and aggressive antihypertensive treatment of insulin-dependent diabetic patients with diabetic nephropathy.
Parving HH; Andersen AR; Smidt UM; Friisberg B; Svendsen PA
Diabetes Care; 1981; 4(4):459-63. PubMed ID: 7049630
[TBL] [Abstract][Full Text] [Related]
26. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH
Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
[TBL] [Abstract][Full Text] [Related]
27. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
28. The effect of beta-blockade and angiotensin converting enzyme inhibition on kidney function in diabetic nephropathy.
Hommel E
J Hypertens Suppl; 1989 Sep; 7(7):S49-51. PubMed ID: 2575661
[TBL] [Abstract][Full Text] [Related]
29. Concerns about diabetic nephropathy in the treatment of diabetic hypertensive patients.
Tolins JP; Raij L
Am J Med; 1989 Dec; 87(6A):29S-33S. PubMed ID: 2688411
[TBL] [Abstract][Full Text] [Related]
30. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy.
Parving HH; Kastrup H; Smidt UM; Andersen AR; Feldt-Rasmussen B; Christiansen JS
Diabetologia; 1984 Dec; 27(6):547-52. PubMed ID: 6442240
[TBL] [Abstract][Full Text] [Related]
31. Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patients.
Mogensen CE
J Diabetes Complications; 1995; 9(4):337-49. PubMed ID: 8573761
[No Abstract] [Full Text] [Related]
32. Is antihypertensive treatment the same for NIDDM and IDDM patients?
Parving HH
Diabetes Res Clin Pract; 1998 Apr; 39 Suppl():S43-7. PubMed ID: 9649959
[TBL] [Abstract][Full Text] [Related]
33. Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy.
Hansen HP; Christensen PK; Tauber-Lassen E; Klausen A; Jensen BR; Parving HH
Kidney Int; 1999 Feb; 55(2):621-8. PubMed ID: 9987086
[TBL] [Abstract][Full Text] [Related]
34. The use of antihypertensive agents in prevention and treatment of diabetic nephropathy.
Parving HH; Rossing P
Curr Opin Nephrol Hypertens; 1994 May; 3(3):292-300. PubMed ID: 7922255
[TBL] [Abstract][Full Text] [Related]
35. Remission and regression of diabetic nephropathy.
Hovind P; Tarnow L; Parving HH
Curr Hypertens Rep; 2004 Oct; 6(5):377-82. PubMed ID: 15341691
[TBL] [Abstract][Full Text] [Related]
36. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
[TBL] [Abstract][Full Text] [Related]
37. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
[TBL] [Abstract][Full Text] [Related]
38. Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
Hansen HP; Rossing P; Tarnow L; Nielsen FS; Jensen BR; Parving HH
Kidney Int; 1995 Jun; 47(6):1726-31. PubMed ID: 7643542
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity.
Baba T; Ishizaki T
Drugs; 1992 Apr; 43(4):464-89. PubMed ID: 1377114
[TBL] [Abstract][Full Text] [Related]
40. Blood pressure, diet and the progression of nephropathy in patients with type 1 diabetes and hypertension.
Sampson MJ; Griffith VS; Drury PL
Diabet Med; 1994 Mar; 11(2):150-4. PubMed ID: 8200198
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
